
Opinion|Videos|May 7, 2025
Medical Billing Strategies for Point-of-Care Testing in Community Pharmacy
Author(s)Duane Jones, BS Pharm
A panelist discusses how medical billing for point-of-care testing represents a significant revenue opportunity for pharmacies. Further, though the process will be initially unfamiliar, pharmacists should learn and control it rather than outsourcing it.
Advertisement
Episodes in this series

Reimbursement and Revenue Generation
Main Discussion Topics:
- Medical billing processes for pharmacy clinical services
- Current Procedural Terminology (CPT)and International Classification of Diseases (ICD) coding fundamentals for pharmacy
- Revenue potential from point-of-care testing
Key Points for Physicians:
- Pharmacies bill using the same CPT/ICD coding system as medical practices
- Four primary goals of point-of-care testing: disease identification, disease monitoring, behavior modification, and reducing barriers to care
- Pharmacy-based testing improves access for patients without primary care providers
Notable Insights:
- Medical billing follows batch processing rather than real-time adjudication
- Developing internal billing expertise prevents revenue loss to third-party vendors
- Patients who use point-of-care testing are frequently aged 18 to 44 years, with approximately one-third lacking a primary care provider
Clinical Significance:
Mastering medical billing processes represents a critical competency for pharmacy’s evolution beyond prescription dispensing, creating sustainable revenue streams through clinical services that address significant health care access gaps.
Advertisement
Related to this article

A high-dose flu vaccine lowered flu- and pneumonia-related hospital stays in patients with chronic lung disease, reinforcing flu and pneumococcal vaccinations.

In a review of records assessing patients with type 2 diabetes, researchers provide a comprehensive detail of strategies leading to diabetes remission though gaps persist.

Exploring the effects of weight-loss and GLP-1 therapies, researchers determine the specific metabolic determinants that lead to patients’ weight reduction.

Observed by APhA and ASHP since 2023, bipartisan support has garnered to give pharmacy workforce suicide awareness its own federally recognized day.

Atogepant reduced migraine days during the perimenstrual period, positioning the medication as a potential first treatment option for the condition.

Chad Worz, PharmD, BCGP, FASCP, discusses the Main Street Pharmacy Access Act, a revolutionary pharmacy-focused bill moving through Congress.
Advertisement
Advertisement
Trending on Drug Topics
1
COVID-19 Vaccine Hesitancy in 2026: How Attitudes Have Shifted
2
Johnson & Johnson Next Major Drugmaker to Require 340B Claims Data
3
Generic Drug Costs Burdening Patients as Much as Brand Name Options
4
Social Media Best Practices for Pharmacists: Why Visibility Matters
5



